Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Illumina, Second Sight.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Betta, Kintor, Moderna, Ocular, Roche, Seqirus, Sigilon, Turnsole.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Controlrad, Misonix.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Kronos, Nervgen, Nicox, Novadip, Ocumension, Pfizer, RDIF, Regeneron, Sanofi.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Asensus Surgical, Medalliance.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Blueprint, Dialectic, Exicure, Exithera, Idorsia, Junshi, Kempharm, Oblato, On Target, RDIF, Saniona, Sorrento, Wellmarker, Xentria.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Astrazeneca, Biontech, Cansino, Carsgen, Gannex, GC, Harbour Biomed, Iaso, Idorsia, Innovent, Johnson & Johnson, Pfizer, Qurebio, RDIF, Regeneron, Roche, Sciwind, Very, Wuhan Institute of Biological Products.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accufix Surgical, Anuncia, Conformis, Fifth Eye, Guardant Health, Masimo, Neurolief.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adverum, Argenx, Astrazeneca, Beigene, Biocryst, Biogen, Eisai, Eyenovia, Fibrogen, Merck, Molecular Targeting Technologies, Oyster Point, RDIF, Sorrento, Strongbridge.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Clinical Enterprise, Fluidigm, Invo Bioscience, Memic Innovative Surgery, Mobidiag, Opgen, Perimeter Medical Imaging AI, Vascular Grafts Solutions, Vetex Medical.